TopFunds

Drug Manufacturers General

Companies

11 companies

Companies table

11 companies
Valuation
Historical Performance:
Fundamentals
Sort by:
01
Eli Lilly And Co LLY

1,233.5 (-1.1)%

41.4
1.8%
-
-
-
18.4%
77.8%

1.6

02
Johnson & Johnson JNJ

273.1 (+0.5)%

31.7
2.8%
-
-
-
13.5%
32.9%

1.2

03
AbbVie Inc. ABBV

265.8 (+0.5)%

74.9
4.2%
-
-
-
3.2%
(130.9)%

3.3

04
Merck & Co., Inc. MRK

156.4 (+3.8)%

125.1
4.1%
-
-
-
13.3%
34.7%

2.4

05
Amgen Inc. AMGN

442.2 (-0.4)%

27.5
4.2%
-
-
-
8.5%
89.1%

3.5

06
Novo Nordisk A/S NVO

48.7 (+3.7)%

11.9
3.5%
-
-
-
18.9%
52.8%

0.7

07
Gilead Sciences, Inc. GILD

148.8 (+1.4)%

(55.7)
7.1%
-
-
-
14.4%
37.6%

1.7

08
Pfizer Inc. PFE

28.6 (+2.1)%

37.8
6.7%
-
-
-
3.7%
9%

4.6

09
Bristol-Myers Squibb Company BMY

67.9 (+1)%

15
8.3%
-
-
-
7.8%
38.1%

2.7

10
Biogen BIIB

220.8 (+1.2)%

39.1
9.1%
-
-
-
4.4%
7.1%

2.5

11
Zoetis ZTS

77.3 (+0.2)%

12.7
7.1%
-
-
-
17.3%
80.3%

2.7

Total
Help

Assumes equal weights for the Base and Lens views. The Holdings view is position-weighted.

+1.2%
32.8
5.4%
260.8%
0%
0%
11.2%
29.8%
2.4